ISSN: 1080-7683

Journal Home

Journal Guideline

Journal of Ocular Pharmacology and Therapeutics Q2 Unclaimed

Mary Ann Liebert Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Ocular Pharmacology and Therapeutics is a journal indexed in SJR in Pharmacology and Ophthalmology with an H index of 72. It has an SJR impact factor of 0,599 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,599.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Ophthalmology (Q2) Pharmacology (Q2) Pharmacology (medical) (Q2) Pharmacology (medical) (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Journal of Ocular Pharmacology and Therapeutics

0,599

SJR Impact factor

72

H Index

89

Total Docs (Last Year)

262

Total Docs (3 years)

3820

Total Refs

591

Total Cites (3 years)

235

Citable Docs (3 years)

1.78

Cites/Doc (2 years)

42.92

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Drug Safety - Case Reports Q2
Cancer Biology and Therapy Q2
Journal of Pharmacological Sciences Q2
AIDS Research and Therapy Q2
Pharmacological Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Ocular Drug Distribution and Safety of a Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in Rabbit

Toxic Effects of Mitomycin-C on Cultured Ciliary Process Cells and Trabecular Meshwork Cells

Ocular Drug Permeation Following Experimental Excimer Laser Treatment on the Isolated Pig Eye

Bioavailability in the Human Eye of a Fixed Combination of Latanoprost and Timolol Compared to Monotherapy

Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry Eye

Effects of Multiple Dosing of Epinephrine on Aqueous Humor Dynamics in Human Eyes

Effect of Brimonidine Tartrate on Ocular Hemodynamics in Healthy Volunteers

A Comparison of the Efficacy and Tolerability of 0.5% Timolol Maleate Ophthalmic Gel-Forming Solution QD and 0.5% Levobunolol Hydrochloride BID in Patients with Ocular Hypertension or Open-Angle Glaucoma

Retinal Function and Histologic Changes Following Intravitreal Injection of Indocyanine Green in a Rabbit Model

Anti-Inflammatory Effects of Lipoxins on Lipopolysaccharide-Induced Uveitis in Rats

Differential Effects of a-Adrenoceptor Agonists on Human Retinal Microvessel Diameter

Intraocular Pressure and Safety in Glaucoma Patients Switching to Latanoprost/Timolol Maleate Fixed Combination from Mono- and Adjunctive Therapies

SHOW MORE ARTICLES

Management of Postvitrectomy Diabetic Vitreous Hemorrhage with Tissue Plasminogen Activator (t-PA) and Volume Homeostatic Fluid-Fluid Exchanger

Structure-Activity Relationship (SAR) Between Some Natural Flavonoids and Ocular Blood Flow in the Rabbit

Studies on Receptor Binding and Signal Transduction Pathways of Unoprostone Isopropyl

3a,5beta-Tetrahydrocortisol Effect on Outflow Facility

Changes in Orbital Hemodynamics Induced by Nipradilol in Healthy Volunteers

Vitrectomy with Fluconazole Infusion: Retinal Toxicity, Pharmacokinetics, and Efficacy in the Treatment of Experimental Candidal Endophthalmitis

Determination of Aldose Reductase Activity in the Eye by Localized Magnetic Resonance Spectroscopy

Effect of Different Dose Schedules of 0.15% Unoprostone Isopropyl on Intraocular Pressure and Pupil Size in the Glaucomatous Beagle

Functional Pharmacological Evidence for EP2 and EP4 Prostanoid Receptors in Immortalized Human Trabecular Meshwork and Non-Pigmented Ciliary Epithelial Cells

Treatment of Failing Glaucoma Filtering Cystic Blebs with Tissue Plasminogen Activator (tPA)

Enhanced Ocular Hypotensive Response to Timolol in Rabbits with Prior Dexamethasone Treatment

Intraocular Properties of Urokinase-Derived Antiangiogenic u6 Peptide in Rabbits